UCalgary scholar is the winner of the first Hopewell M.I.N.D. Prize

Calgary, AB – Dr. Peter Stys, MD, a professor at the University of Calgary is the first winner of the $1 million Hopewell M.I.N.D. Prize. His research project was selected by an international panel of experts, including representatives from Harvard Medical School, the Weizmann Institute of Science, and the Howard Hughes Medical Institute. The judges evaluated the top three finalists on the potential impact of their proposed research projects. The winning project explores the non-immune role of B cells in the pathogenesis of multiple sclerosis (MS).

“I have deep gratitude to the Hotchkiss Brain Institute and Sanders Lee for supporting our science – it is a research topic for which it is difficult to find support otherwise. The M.I.N.D. Prize is an incredible initiative and has given my lab a huge opportunity to conduct transformative research in medicine.”

Dr. Peter Stys, MD, professor at the Cumming School of Medicine (CSM), and member of the Hotchkiss Brain Institute (HBI)

The Hopewell M.I.N.D. (Maximizing Innovation in Neuroscience Discovery) Prize was created in 2021 through a $10 million commitment from Calgarian Sanders Lee. The prize aims to spark innovation through supporting cutting-edge research at the HBI.

“What defines an entrepreneurial mindset, whether in research or in the community, is the willingness to take chances and go for a high impact outcome. The M.I.N.D. Prize brings these high-impact ideas to Calgary and provides opportunity for potential lifesaving discoveries for mankind.”

Sanders Lee, philanthropist and Calgary business leader

As winner of the 2022 prize, Stys plans to use the award to drive research in the study of B cells from MS patients, as well as look at the role of the Epstein Barr virus in the chronic disease. Stys aims to determine the role of the virus in the transformation of B cells into toxin producing factories that take up residence in the central nervous system.

“It is remarkable, the possibilities for amazing impact that will come out of this award. There is so much potential for unique discovery.”

Dr. David Park, PhD, director of the HBI at the CSM

The two runners up for the prize were Dr. Garnette Sutherland, MD, with his project CellARM, a micro-robotic system for data driven surgery; and Dr. Minh Dang Nguyen, PhD, who is looking at the connection between the gut microbiome and the brain lymphatic system in neurodegenerative disease.

The Hopewell M.I.N.D. Prize competition for the 2022-23 year will open soon. For more information visit the webpage.

Peter Stys, MD, is a professor in the Department of Clinical Neurosciences at the Cumming School of Medicine, and a member of the Hotchkiss Brain Institute.

Media inquiries

Kelly Johnston
Senior Communications Specialist, Media Relations
Cumming School of Medicine
403-617-8691
kelly.johnston2@ucalgary.ca

About the University of Calgary
UCalgary is Canada’s entrepreneurial university, located in Canada’s most enterprising city. It is a top-five research university and one of the highest-ranked universities of its age. Founded in 1966, its 35,000 students experience an innovative learning environment, made rich by research, hands-on experiences and entrepreneurial thinking. It is Canada’s leader in the creation of start-ups. Start something today at the University of Calgary.

For more information, visit ucalgary.ca. Stay up to date with UCalgary news headlines on Twitter @UCalgary. For access to UCalgary news releases, images and b-roll, and details on faculties and how to reach experts, check out our newsroom at ucalgary.ca/newsroom.